VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- SPARC AI Inc. (the “Company”) (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0), developer of the Overwatch GPS-denied navigation and targeting platform, today announced the appointment of Matt McCrann as Chief Executive Officer of its U.S. subsidiary. McCrann will lead SPARC AI’s North American expansion, establishing the Company’s operational presence and deepening engagement with U.S. defense, federal, and allied government customers. The appoint ...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CALGARY, Alberta, March 02, 2026 (GLOBE NEWSWIRE) -- Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company”) is pleased to announce that it has closed its previously announced non‑brokered private placement financing (the “Financing”), which was disclosed on February 11, 2026 in connection with the Company’s proposed strategic asset acquisition with Canadian Di ...

Zumilokibart (APG777) trials continue to advance in atopic dermatitis (AD) with plans for expansion indications underway:- APEX Phase 2 Part A 52-week data expected this month- APEX Phase 2 Part B 16-week data expected in Q2 2026- Phase 3 trial initiation in AD anticipated in 2H 2026- Successful expansion of zumilokibart beyond AD demonstrated in asthma Phase 1b trial; details on asthma and eosinophilic esophagitis (EoE) trials expected later this year Phase 1b head-to-head trial of APG279 (zumilokibart + A ...

VANCOUVER, British Columbia, March 02, 2026 (GLOBE NEWSWIRE) -- Westhaven Gold Corp. (TSX-V: WHN) (OTCQB: WTHVF) (“Westhaven” or the “Company”) announces the appointments of Allison Rippin Armstrong as Vice President, Indigenous and Community Relations, and Pamela O’Hara as Vice President, Permitting and Government Affairs, effective April 1, 2026. Ken Armstrong, President and Chief Executive Officer of Westhaven, commented, "I am pleased to welcome Allison and Pamela to Westhaven at a defining stage for th ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, March 02, 2026 (GLOBE NEWSWIRE) -- Sirios Resources Inc. (TSX-V: SOI; OTCQB: SIREF) (the "Company") is pleased to announce that it has entered into an agreement with National Bank Capital Markets, as co-bookrunner and co-lead agent with MDCP Securities Ltd. (together, the "Agents"), in connection with a "best efforts" private placement offering under the LIFE Exemption (as defined herein) of: (i) up t ...

Continued strong financial results and cash generation, achieving all 2025 guidance metrics Full year earnings growth; GAAP EPS up 3%, Adjusted EPS up 19% Returned $791 million to shareholders through share repurchases and dividends Multi-year financial framework focused on growth in revenue, earnings, and cash flow BOCA RATON, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT), a leading provider of security, interactive, and smart home solutions serving residential and small business customers ...

Core Viewpoint - CTO Realty Growth, Inc. has announced the acquisition of Palms Crossing, an open-air retail center in McAllen, Texas, for $81.6 million, enhancing its portfolio in high-growth markets [1][2]. Acquisition Details - The Palms Crossing property spans 399,000 square feet and is currently 98% leased, featuring major tenants such as Best Buy, Hobby Lobby, Burlington Coat Factory, Barnes & Noble, and Nike [2]. - The property is situated on 47 acres with a population of approximately 200,000 within a five-mile radius, and includes two pad sites on about six acres for future development opportunities [2]. Financial Impact - Following this acquisition, Texas will become the Company's third largest state by annualized cash base rent (Cash ABR), with the combined percentage of Cash ABR from Georgia, Florida, Texas, and North Carolina increasing to 85% [3]. - The acquisition will be initially funded through available cash and a revolving credit facility, with plans to sell another property in mid-2026 to retroactively fund the Palms Crossing acquisition [3]. Company Overview - CTO Realty Growth, Inc. specializes in owning and operating high-quality, open-air shopping centers in the Southeast and Southwest markets of the United States [4]. - The Company also manages and holds a significant interest in Alpine Income Property Trust, Inc., a publicly traded net lease REIT [4].

Core Viewpoint - Endeavour Silver Corp. announces significant changes in its Board of Directors and senior management team, marking a new phase of growth and execution as it aims to become a senior silver producer [1][12]. Management Changes - George Paspalas has been appointed to the Board of Directors, effective March 1, 2026, bringing over 40 years of international leadership experience in the mining sector, including his role as President and CEO of MAG Silver Corp. [2][4] - Don Gray, the current Chief Operating Officer, will retire on April 30, 2026, after playing a crucial role in transforming the Terronera project and shaping the company's operational success [5][8]. - Luis Castro has been appointed as the new Chief Operating Officer, effective March 1, 2026, having over 22 years of experience with Endeavour and a strong background in exploration and geology [7][9]. - Gord Bussieres has been appointed as Vice President, Projects, bringing more than 40 years of experience in project development and technical oversight [10][12]. Company Operations and Strategy - Endeavour Silver operates three underground mines in Mexico and Peru, supported by a robust development pipeline aimed at advancing its long-term strategy [1][12]. - The company is focused on building momentum and driving strategic priorities forward under the new leadership, particularly with the development of the Pitarrilla project [9][12].

Core Insights - Pharvaris is a late-stage biopharmaceutical company focused on developing oral bradykinin B2 receptor antagonists to address unmet needs in bradykinin-mediated diseases, particularly hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH) [1][12] Clinical Data and Efficacy - The Phase 3 RAPIDe-3 study demonstrated that deucrictibant achieved rapid and sustained symptom relief for HAE attacks, with a median time to onset of symptom relief of 1.28 hours compared to over 12 hours for placebo [3][6] - Deucrictibant met all primary and secondary efficacy endpoints, with 90.4% of treated attacks achieving symptom relief within 12 hours, and a median time to complete resolution of 11.95 hours versus over 48 hours for placebo [3][6] - The long-term safety and efficacy of deucrictibant were supported by the Phase 2 CHAPTER-1 study, showing a reduction in attack rate from 2.18 attacks per month to 0.12 attacks per month over approximately three years [5][7] Quality of Life Improvements - Treatment with deucrictibant resulted in clinically meaningful improvements in health-related quality of life (HRQoL) and higher treatment satisfaction for participants over the long term [8] Novel Biomarker Development - Pharvaris has developed a kinin biomarker assay to measure bradykinin levels in plasma, which may aid in the characterization and management of bradykinin-mediated angioedema [10] Product Development and Regulatory Status - Deucrictibant is being developed in two formulations: an immediate-release capsule for on-demand treatment and an extended-release tablet for prophylactic use [11] - The company is preparing marketing authorization applications for the immediate-release capsule and is conducting a global pivotal Phase 3 study for the extended-release tablet, with topline data expected in Q3 2026 [12]

Core Viewpoint - Theon International Plc is hosting a webcast on March 6, 2026, to discuss its investment case, business model, operations, recent news, financial results, and outlook [2][3]. Group 1: Webcast Details - The webcast will be led by Philippe Mennicken, Deputy CEO and Business Development Director [3]. - It is open to all existing and potential investors, with a live Q&A session available [3]. - Investors can register for free on the Investor Meet Company platform [3]. Group 2: Company Overview - Theon Group develops and manufactures advanced night vision and thermal imaging systems for defense and security applications [5]. - Established in 1997 in Greece, Theon Group has a significant international presence with subsidiaries and production facilities in multiple countries, including the US, Germany, and South Korea [5]. - The company has over 250,000 systems in service across 72 countries, including 26 NATO member countries [5]. - Theon International Plc has been listed on Euronext Amsterdam since February 2024 [5].